Nyxoah (NYXH) has released an update.
Nyxoah SA, a Belgian medical technology company, has entered into an underwriting agreement with Cantor Fitzgerald & Co. to sell 5,374,755 ordinary shares, with an option for the underwriters to purchase an additional 806,213 shares to cover over-allotments. The company has filed a registration statement with the SEC, which is effective and includes a prospectus detailing the securities and the offering. Nyxoah confirms compliance with all regulatory requirements and the absence of any SEC actions that could impede the prospectus’s use.
For further insights into NYXH stock, check out TipRanks’ Stock Analysis page.
